Corneal Neovascularization clinical trials

Explore recruiting corneal neovascularization clinical trials.

Recruiting corneal neovascularization studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Corneal Neovascularization trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Antisense Oligonucleotide Eye Drops Against IRS-1 to Treat Pathological Corneal Neovascularisation in Aniridia-Associated Keratopathy (Olisens-Aniridia)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A 4-Week, Phase II, Multicenter, Randomized, Double-Masked, Vehicle-Controlled, Parallel Group Study With 2 Weeks of Follow-Up to Evaluate Safety and Efficacy of Two Different Dosages of Isocyclosporin A Eye Drop Solution Versus Vehicle in Adult Patients with Atopic Keratoconjunctivitis (AKC).

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Corneal Neovascularization trials by city

Corneal Neovascularization clinical trials

Recruiting corneal neovascularization studies right now

Clinical Study of Intrastromal Anti-VEGF Injection for Corneal Neovascularization.

Fine-needle Diathermy Combined With Subconjunctival Bevacizumab for Corneal Neovascularization

Corneal Crosslinking for Treatment of Corneal Neovascularization

Also recruiting in Europe

Antisense Oligonucleotide Eye Drops Against IRS-1 to Treat Pathological Corneal Neovascularisation in Aniridia-Associated Keratopathy (Olisens-Aniridia)

A 4-Week, Phase II, Multicenter, Randomized, Double-Masked, Vehicle-Controlled, Parallel Group Study With 2 Weeks of Follow-Up to Evaluate Safety and Efficacy of Two Different Dosages of Isocyclosporin A Eye Drop Solution Versus Vehicle in Adult Patients with Atopic Keratoconjunctivitis (AKC).

Corneal Neovascularization trials by city

Other conditions